HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element

AIDS

Volumn 11, Issue 2, 1997, Pages 139-146

  Roebuck, Kenneth A ^a   Rabbi, Mohammed F ^a   Kagnoff, Martin F ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Activating protein 1; Tat; TATA box; Trans activation response element; Transcription

Indexed keywords

CELL EXTRACT; CHLORAMPHENICOL ACETYLTRANSFERASE; LUCIFERASE; ONCOPROTEIN; TRANS ACTING FACTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS DNA;

ARTICLE; BINDING SITE; COLON MUCOSA; CONTROLLED STUDY; DNA SEQUENCE; DNA TRANSCRIPTION; ENZYME ACTIVITY; GENE CONSTRUCT; GENE FUSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REPORTER GENE; TRANSACTIVATION;

ANIMALS; BINDING SITES; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LUCIFERASES; PROLACTIN; PROMOTER REGIONS (GENETICS); RATS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0031023206     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199702000-00002     Document Type: Article

References (63)

1. Gaynor R: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992, 6:347-363.
2. Dingwall C, Ernberg I, Gait MJ, et al.: Human immunodeficiency virus 1 Tat protein binds transactivation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 1989, 86:6925-6929.
3. Churcher M, Lamont C, Dingwall C, et al.: High affinity binding of TAR RNA by the human immunodeficiency virus Tat protein requires amino acid residues flanking the basic domain and base pairs in the RNA stem. J Mol Biol 1993, 230:90-110.
4. Roy S, Delling U, Chen C-H, Rosen CA, Sonenberg N: A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev 1990, 4:1365-1373.
5. Ruben S, Perkins A, Purcell R, et al.: Structural and functional characterization of HIV Tat protein. J Virol 1989, 63:1-8.
6. Dingwall C, Ernberg I, Gait MJ, et al.: HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J 1990, 9:4145-4153.
7. Luo Y, Madore SJ, Parslow TG, Cullen BR, Peterlin BM: Functional analysis of interactions between tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J Virol 1993, 67:5617-5622.
8. Muesing MA, Smith DH, Capon DJ: Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 1987, 48:691-701.
9. Selby MJ, Bain ES, Luciw P, Peterlin BM: Structure, sequence and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev 1989, 3:547-558.
10. Marciniak RA, Calnan BJ, Frankel AD, Sharp PA: HIV-1 Tat protein trans-activates transcription in vitro. Cell 1990, 63:791-802.
11. Zhou Q, Sharp PA: Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J 1995, 14:321-328.
12. Bohan CA, Kashanchi F, Ensoli B, Buonaguro L, Boris-Lawrie KA, Brady JN: Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr 1992, 2:391-407.
13. Laspia MF, Wendel P, Mathews MB: HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J Mol Biol 1993, 232:732-716.
14. Kato H, Suminmoto H, Pognonec P, Chen CH, Rosen CA, Roeder RG: HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev 1992, 6:655-666.
15. Marciniak RA, Sharp PA: HIV-1 Tat protein promotes formation of more processive elongation complexes. EMBO J 1991, 10:4189-4196.
16. Jones KA, Peterlin BM: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1994, 63:717-743.
17. Lu X, Walsh TM, Peterlin BM: The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J Virol 1993, 67:1752-1760.
18. Laspia MF, Rice AP, Mathews MB: HIV-1 Tat protein increases transcription initiation and stabilizes elongation. Cell 1989, 59:283-292.
19. Berkhout B, Jeang K-T: Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 1992, 66:139-149.
20. Rosen CA, Sodroski JG, Haseltine WA: The location of cis-acting regulatory sequences in the human T-cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1985, 41:813-823.
21. Olsen HS, Rosen CA: Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression. J Virol 1992, 66:5594-5597.
22. Garcia JA, Harrich D, Soultanakis E, Wu F, Mitsuyasu R, Gaynor RB: Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J 1989, 8:765-778.
23. Rittner K, Churcher MJ, Gait MJ, Karn J: The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J Mol Biol 1995, 248:562-580.
24. Jones KA, Kadonaga J, Luciw P, Tjian R: Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 1986, 232:755-759.
25. Huang L-M, Jeang K-T: Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function. J Virol 1993, 67:647-6944.
26. Kamine J, Chinnadurai G: Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J Virol 1992, 66:3932-3936.
27. Sune C, Garcia-Blanco MA: Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J Virol 1995, 69:6572-6576.
28. Jeang K-T, Chun R, Lin NH, Gatignol A, Glabe CG, Fan H: In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol 1993, 67:6224-6233.
29. Kashanchi F, Piras G, Radonovich MF, et al.: Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 1994, 367:295-299.
30. Yankulov K, Blau J, Purton T, Roberts S, Bentley DL: Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 1994, 77:749-759.
31. Kamine J, Subramanian T, Chinnadurai G: Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1991, 88:8510-8514.
32. Southgate CD, Green MR: The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev 1991, 5:2496-2507.
33. Berkhout B, Gatignol A, Rabson AB, Jeang K-T: TAR-independent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 1990, 62:757-767.
34. Han P, Brown R, Barsoum J: Transactivation of heterologous promoters by HIV-1 tat. Nucleic Acids Res 1991, 19:7225-7229.
35. Kamine J, Subramanian T, Chinnadurai G: Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators. J Virol 1993, 67:6828-6834.
36. Selby MJ, Peterlin BM: Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 1990, 62:769-776.
37. Ghosh S, Selby MJ, Peterlin BM: Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. J Mol Biol 1993, 234:610-619.
38. Southgate C, Zapp M, Green MR: Activation of transcription by HIV-1 Tat protein tethered to a nascent RNA through another protein. Nature 1990, 345:640-642.
39. Tiley LS, Madore SJ, Malim MH, Cullen BR: The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev 1992, 6:2077-2087.
40. Roebuck KA, Brenner DA, Kagnoff MF: Identification of c-Fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J Clin Invest 1993, 92:1336-1348.
41. Nelson C, Albert VR, Elsholtz HP, Lu LI, Rosenfeld MG: Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 1988, 239:1400-1405.
42. Siddiqui A, Gaynor R, Srinivasan A, Mapoles J, Farr RW: Trans-activation of viral enhancers including the long terminal repeat of the human immunodeficiency virus by hepatitis B virus X protein. Virology 1989, 169:479-484.
43. Roebuck KA, Sheng Gu D, Kagnoff MF: Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 1996, 10:819-826.
44. Omary MB, Brenner DA, deGrandpre LY, Roebuck KA, Richman DD, Kagnoff MF: HIV-1 infection and expression in human colonic cells: Infection and expression in CD4+ and CD4- cell lines. AIDS 1991, 5:275-281.
45. Chiu R, Angel P, Karin M: Jun-B differs in its biological properties from and is a negative regulator of c-Jun. Cell 1989, 59:979-986.
46. Karin M: The AP1 complex and its role in transcriptional control by protein kinase C. In The Hormonal Control of Gene Transcription. Edited by Cohen P, Foulkes JG. Amsterdam: Elsevier Science; 1991:235-253.
47. Brenner DA, O'Hare M, Angel P, Chojkier M, Karin M: Prolonged activation of Jun and collagenase by TNFα. Nature 1989, 337:661-663.
48. Angel P, Imagawa M, Chiu R, et al.: Phorbol ester-inducible genes containing a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987, 49:729-739.
49. Zawel L, Reinberg D: Common themes in assembly and function of eukaryotic transcription complexes. Annu Rev Biochem 1995, 64:533-561.
50. Chiang C-M, RG Roeder: Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 1995, 267:531-536.
51. Dynlacht BD, Hoey T, Tjian R: Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 1991, 66:563-576.
52. Nelbock P, Dillon PJ, Perkins A, Rosen CA: A cDNA for protein that interacts with the HIV Tat transactivator. Science 1990, 248:1650-1653.
53. Desai K, Loewenstein PM, Green M: Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter. Proc Natl Acad Sci USA 1991, 88:8875-8879.
54. Song C-Z, Loewenstein PM, Green M: Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s). Proc Natl Acad Sci USA 1994, 91:9357-9361.
55. Herrmann CH, Rice AP: Lentivirus Tat proteins specifically associate with a cellular kinase, TAK, the hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J Virol 1995, 69:1612-1620.
56. Taylor JP, Pomerantz RJ, Raj GV, et al.: Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. J Virol 1994, 68:3971-3981.
57. Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B: The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J Virol 1994, 68:2677-2682.
58. Westendorp MO, Li-Weber M, Frank RW, Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 1994, 68:4177-4185.
59. Scala G, Ruocco MR, Ambrosino C, et al.: The expression of interleukin 6 gene is induced by the human immunodeficiency virus 1 Tat protein. J Exp Med 1994, 179:961-971.
60. Kim Y-S, Risser R: TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by Tat protein. J Virol 1993, 67:239-248.
61. Chowdhury M, Kundu M, Khalili K: GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JC in cells derived from central nervous system. Oncogene 1993, 8:887-892.
62. Scharer SL, Vlach J, Pitha P: Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J Virol 1996, 70:6937-6946.
63. Robinson D, Elliott JF, Chang L-J: Retroviral vector with a CMV-EI/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat. Gene Ther 1995, 2:269-278.